Filing Details
- Accession Number:
- 0001144204-14-049403
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-13 17:00:25
- Reporting Period:
- 2014-08-11
- Filing Date:
- 2014-08-13
- Accepted Time:
- 2014-08-13 17:00:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1509420 | D Chandra Lovejoy | 3000 Kent Ave Ste A1-100 West Lafayette IN 47906 | Vp Of Regulatory Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-08-11 | 479 | $3.06 | 6,729 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-08-11 | 21,000 | $3.55 | 27,729 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-08-11 | 21,479 | $7.00 | 6,250 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2014-08-11 | 479 | $0.00 | 479 | $3.06 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2014-08-11 | 21,000 | $0.00 | 21,000 | $3.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-11-14 | No | 4 | A | Direct | |
| 17,443 | 2022-02-28 | No | 4 | A | Direct |
Footnotes
- The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
- This option is fully vested and immediately exercisable.
- Shares subject to the option vest 1/4 annually over a period of 4 years beginning on February 29, 2013.
Billionaire Hedge Funds
